More Than 6 Million Hispanics in the US Suffer From Acid Reflux Disease Yet Most Are Unaware of its Seriousness According to a New Survey
Study Shows Need for Awareness about Acid Reflux Disease (ARD) and its Possible Long-Term Consequences
6.1 million Hispanics in the United States suffer from acid reflux disease(1), however a survey sponsored by AstraZeneca that was conducted in five U.S. cities with large Hispanic density, reveals that more than sixty percent (66%) of Hispanics are not familiar with common terms to describe the condition known as acid reflux. According to the new survey, although Hispanics are familiar with the symptoms of acid reflux, they don’t know that these symptoms may be part of a potentially more serious medical problem.
Suffering frequent symptoms of acid reflux, may not only affect everyday productivity and sleep, but can also cause potentially serious damage to the esophagus if not treated properly.
Acid reflux occurs when harsh acid passes back up into the esophagus, causing the inner lining of the esophagus to become irritated. A valve localized between the esophagus and the stomach called the Lower Esophageal Sphincter (LES) muscle stops closing properly, allowing the stomach acid to go up to the esophagus. This can irritate the esophagus. Despite low awareness of the condition, twenty-one percent (21%) of people interviewed said they suffer from acid reflux related symptoms; two or more times a week.
Survey Results:
– Seventy-eight percent (78%) of participants suffer from heartburn
– Sixty-six percent (66%) noticed acidic or sour taste in their mouth
– Fifty-seven percent (57%) suffered from belching
– Twenty-three percent (23%) of Hispanic women tend to suffer from the symptoms compared to sixteen (16%) of Hispanic men, few participants felt these symptoms warrant medical attention.
“In some people, their normal esophageal tissue may lose its healthy condition (and develop erosions),” said Dr. Greer. “Only a doctor can determine if someone has these erosions and treat them accordingly.”
Acid reflux is potentially serious and may be treated. For more information, please call (toll free) 1-866-271-7278. Select option 2.
AstraZeneca’s public education efforts expand beyond gastrointestinal health to a variety of important conditions affecting the Hispanic community including: cardiovascular disease, childhood asthma, mental health and oncology.
Survey Methodology
The survey was conducted in five markets (Los Angeles, New York, Chicago, Miami and Houston) with 1,001 Hispanics from August 8-17, 2005 by Impacto Group LLC. This survey was sponsored by AstraZeneca. More information on the survey is available upon request.
About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world’s leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. In the United States, AstraZeneca is a $9.6 billion healthcare business with more than 12,000 employees. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
About Acid Reflux
Of all the symptoms related to acid reflux, heartburn is the most common. Other symptoms of acid reflux can include: difficulty when swallowing (due to the acid that goes back to the esophagus) and regurgitation (sensation of stomach contents backing up into the throat).
Although acid reflux is caused by the back up of gastric acid into the esophagus, some foods or activities may also trigger these symptoms; for example, bending or lying down after eating, using tight clothing, eating chocolate, tea, alcohol or foods with high fat contents may trigger the symptoms. Doctors recommend keeping a journal to help them identify the foods and activities that benefit people who suffer from acid reflux. Likewise, it is important that persons suffering from these symptoms see a doctor who can evaluate them and recommend a treatment program.
1. Cheskin Research, August 2004
2. NHWS 2004, Consumer Health Sciences
(info from Hispanic PR Wire)